dromlakhani Educating Patients and Families About the Clinical Features of Remission in Cushing's Syndrome
STEP 1 — Gather Information
Confirm remission status by reviewing postoperative serum cortisol, late-night salivary cortisol, or UFC; assess resolution of CS symptoms (weight, hypertension, glucose, mood); review comorbidities and current medications.
STEP 2 — Rule In / Rule Out
Rule in remission if postoperative serum cortisol <5 µg/dL (or UFC normal) with normal diurnal rhythm; rule out persistent hypercortisolism if cortisol remains elevated or symptoms persist, and rule out hypocortisolism if cortisol is low with signs of adrenal insufficiency.
STEP 3 — Classify or Stratify
Stratify remission state as eucortisolism (normal cortisol), hypocortisolism (low cortisol needing glucocorticoid replacement), or hypercortisolism (persistent excess requiring further treatment).
STEP 4 — Decide
For eucortisolism, provide education on expected clinical improvements, timeline for symptom resolution, importance of lifelong monitoring for recurrence, and management of residual comorbidities; for hypocortisolism, educate on glucocorticoid replacement and stress dosing; for hypercortisolism, advise additional treatments per guideline.
Clinical Guardrails / Mimics / Pitfalls
Do not confuse glucocorticoid withdrawal symptoms (fatigue, nausea, weight loss) with disease recurrence; avoid premature discontinuation of replacement therapy before HPA axis recovery; do not rely solely on symptoms for remission confirmation—use biochemical testing; monitor for Nelson’s syndrome after bilateral adrenalectomy.
Concrete Clinical Example
A 42-year-old woman with Cushing’s disease undergoes transsphenoidal adenomectomy; postoperative morning cortisol is 1.2 µg/dL and late-night salivary cortisol is normal. She reports improved energy and weight loss. Educate her and her family that symptoms will continue to improve over 6–12 months, that lifelong annual screening with late-night salivary cortisol is needed to detect recurrence, and that she may experience temporary glucocorticoid withdrawal requiring stress dosing during illness.
Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2015, DOI:10.1210/jc.2015-1818